Einat Brill Almon
2021
In 2021, Einat Brill Almon earned a total compensation of $627.8K as Senior Vice President, Chief Development Officer at Protalix BioTherapeutics, a 29% decrease compared to previous year.
Compensation breakdown
| Option Awards | $196,784 |
|---|---|
| Salary | $339,937 |
| Other | $91,044 |
| Total | $627,765 |
Almon received $339.9K in salary, accounting for 54% of the total pay in 2021.
Almon also received $196.8K in option awards and $91K in other compensation.
Rankings
In 2021, Einat Brill Almon's compensation ranked 10,198th out of 12,415 executives tracked by ExecPay. In other words, Almon earned more than 17.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,198 out of 12,415 | 18th |
Division Manufacturing | 4,511 out of 5,505 | 18th |
Major group Chemicals And Allied Products | 2,015 out of 2,375 | 15th |
Industry group Drugs | 1,786 out of 2,096 | 15th |
Industry Biological Products, Except Diagnostic Substances | 390 out of 449 | 13th |
Source: SEC filing on April 29, 2022.
Almon's colleagues
We found three more compensation records of executives who worked with Einat Brill Almon at Protalix BioTherapeutics in 2021.